Ling Wang analyst JPMORGAN

Currently out of the existing stock ratings of Ling Wang, 35 are a BUY (100%).

Ling Wang

Work Performance Price Targets & Ratings Chart

Analyst Ling Wang, currently employed at JPMORGAN, has had 46.46% of price targets met with an average potential upside of 45.52%, reached in 446 days on average. Previously, Ling Wang worked at BTIG, OPPENHEIMER, CHARDAN CAPITAL.

Ling Wang has documented 79 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.

Wall Street Analyst Ling Wang

Analyst best performing recommendations are on LJPC (LA JOLLA PHARMACEUTICAL CO).
The best stock recommendation documented was for LJPC (LA JOLLA PHARMACEUTICAL CO) on 4/20/2015. The price target of $43 was fulfilled within 141 days with a profit of $23.93 (125.49%), with a performance score of 8.9.

Average potential price target upside

IMGN ImmunoGen RLYP Relypsa RMTI Rockwell Medical DQ Daqo New Energy Corp ADR LJPC La Jolla Pharmaceutical Co MACK Merrimack Pharmaceuticals TCON TRACON Pharmaceuticals AGIO Agios Pharm CGEN Compugen GERN Geron ISEE IVERIC bio ENLV Enlivex Therapeutics Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Feb-2024

$31

$31

2 years 9 months 5 days ago
(12-Feb-2024)

5/6 (83.33%)

$-0.23 (-0.74%)

121

Buy Since 04-Dec-2023

$31

$31

2 years 11 months 13 days ago
(04-Dec-2023)

9/9 (100%)

$1.78 (6.09%)

417

Buy Since 16-Nov-2022

$31

$26

2 years 11 months 16 days ago
(01-Dec-2023)

4/4 (100%)

$1.68 (5.73%)

114

Buy Since 01-Dec-2023

$31

$12

2 years 11 months 16 days ago
(01-Dec-2023)

2/2 (100%)

$1.68 (5.73%)

294

Buy Since 01-Dec-2023

$31

2 years 11 months 16 days ago
(01-Dec-2023)

6/6 (100%)

$1.68 (5.73%)

565

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ling Wang?

On 2009
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?